Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
As Liquidia releases its Q4 2025 results, investors crave clarity on revenue, burn rate, and milestones. This article...
Meta is plowing ahead with AI investments. This article explains why the reason meta's spending spree could stay on t...
A new $6,000 senior tax deduction comes with an income-based phase-out that can trim or erase relief for those who wo...
A family debates paying elderly parents $1,000 a month for babysitting, but opts to fund an investment for the parent...
In just one year, Nebius Group has moved from curiosity to a marquee name in AI infrastructure. This piece unpacks wh...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
OpenAI's ongoing losses highlight the high-cost path of AI leadership. This article explains why two blue-chip AI sto...
New hiring data arrives as investors weigh whether layoffs to boost efficiency undermine long-term growth. Experts wa...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...
A calmer catastrophe year can boost underwriting margins and reserve efficiency. This piece explains why allstate hav...
Netflix is trading well below its latest peak. This article breaks down what the drop means, what history suggests ab...